Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. - Wikidata - wikimedia - TriplyDB

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling.

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling.

http://www.wikidata.org/entity/Q37395388

about

Inferring clonal composition from multiple sections of a breast cancer Evaluation and consequences of heterogeneity in the circulating tumor cell compartment Tumour Cell Heterogeneity Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer The path to routine use of genomic biomarkers in the cancer clinic Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer Translational implications of tumor heterogeneity Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine Tumour heterogeneity and the evolution of polyclonal drug resistance Better therapeutic trials in ovarian cancer.Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment Patient-derived tumour xenografts for breast cancer drug discovery Changing genetic paradigms: creating next-generation genetic databases as tools to understand the emerging complexities of genotype/phenotype relationships Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data.Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors eTumorType, An Algorithm of Discriminating Cancer Types for Circulating Tumor Cells or Cell-free DNAs in Blood.Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.The NF1 somatic mutational landscape in sporadic human cancers.Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma.Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins PyClone: statistical inference of clonal population structure in cancer.Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing.Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease.Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.Fast and scalable inference of multi-sample cancer lineages Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.

P2860

Q21145293-A2AB43A3-B2E2-4085-B23A-07275286E75C Q26765357-04EBA966-2BA7-4457-B791-EA6A1A6E718B Q26765895-1FD391AC-9E9B-4A6B-AF89-29C21556D18B Q26776018-99C0A97C-75B0-411F-AED6-436043212172 Q26780387-039D55DF-853D-4080-BEB1-E5F2E7335DA4 Q26782733-AC02F564-D3CB-4A5F-AE14-D049B8C90198 Q26801063-4BC11FC3-AA58-4E5F-AE06-BC40508D5C34 Q26801525-89FD7580-89C6-4096-9FDD-4B29D715071D Q26822823-A06F30A3-CB08-4BC8-A750-42BC3FA79909 Q26825186-B1303C37-D966-4E41-B628-E33576DDBFB3 Q26866803-1F4382EF-884B-41C5-AD9B-B350E32C4A8C Q27691432-82ED90AE-55E7-4395-8A4C-508C5EBC32CB Q27853144-02C1420C-F710-4684-A4C7-4AC2FC4E784C Q28066904-FB3ECA7E-D781-4173-A065-E6A5B198AF57 Q28080046-ED36046C-3452-448C-A1FA-5F8B5FBBCC0D Q28387022-B1DED7CA-1177-4B01-B983-403E28681A7D Q28649475-5EEC6A2F-D0AD-4D90-B843-E1DCB7C4002A Q30250107-1E1CFE7D-53CF-46C5-ABDD-A2A0E6A174EE Q30838548-F87AE7D3-C5E4-466B-9620-D6776EC14CA1 Q33566747-7B3C3D43-C060-4D88-B01B-4323A059B52F Q33631634-1FA88319-66B2-4F00-A8C3-4511A8AB1723 Q33810500-4F766018-DB69-456F-B9BB-711E3CC4EF32 Q33823065-AFAAE625-FB27-4214-8CC9-2DAA4D000A97 Q33823452-64C90A04-5572-414D-BFE3-C1B63A9E2DE3 Q33913967-F7844DAD-6EED-4156-8363-8794F506568D Q33952816-A1C72831-9602-44E9-9566-285D60DEC85C Q34274053-79DADA6E-2B47-4EB8-A850-9BDA77AA699A Q34410309-8F2D1912-4D31-4FA8-97DF-394544FEF121 Q34500359-3CE0E3BF-4072-4746-BAA5-5605E7CC1C22 Q34538858-F2A22BA6-2C4F-4C91-877B-E677F5D7F4AE Q35044404-7AD29705-304C-4C1E-9CDB-CE23106DF0EE Q35060446-7B996CCC-4EBC-4965-A86D-85A39541B095 Q35136473-092041EA-76F2-4426-A375-92B76D21ECF1 Q35147619-981DB122-3001-4DB2-8BD2-EF922405CBFD Q35264283-0C24C4C0-6EFE-45C3-A8C8-237A36B6D2AB Q35595719-A9914BBC-B296-4E88-8F50-52A581949DCB Q35836909-469EC693-7070-448F-9C99-0C1163048645 Q35848267-07683A59-EF3E-4B93-8A5A-34EC381DD3B3 Q35856294-CE5E647D-3B14-4F49-AE69-18C9EFFEB8E9 Q35863199-6B55D657-8DD6-41DB-B41B-079A256394C8

P2860

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling.

http://www.wikidata.org/entity/Q37395388

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Distinct evolutionary trajecto ...... spatial mutational profiling.

@en

Distinct evolutionary trajecto ...... spatial mutational profiling.

@nl

type

label

Distinct evolutionary trajecto ...... spatial mutational profiling.

@en

Distinct evolutionary trajecto ...... spatial mutational profiling.

@nl

prefLabel

Distinct evolutionary trajecto ...... spatial mutational profiling.

@en

Distinct evolutionary trajecto ...... spatial mutational profiling.

@nl

P1433

Q37395388-D6A2CC31-DB96-4BF4-8D46-60B26EA90E5F

P1476

Q37395388-D922BDD1-C10D-4BAA-BD79-CBB06A14DFBF

P2093

Q37395388-1901693D-8B75-48F5-91A1-DFAF36308136

Q37395388-260A0294-5096-409E-A6F3-9DB0E83D4BB2

Q37395388-403DA005-A252-4031-981C-F2A1FFC13C07

Q37395388-482236EC-DD31-4065-8600-43392C012572

Q37395388-4FC50D42-7D19-4C79-A011-F00EB7147AE2

Q37395388-53E384BD-3F47-43A7-94B5-C6296AD1F9EF

Q37395388-5CE00AB4-2663-479D-8AA7-192EA922BBDB

Q37395388-5DD360ED-6D1A-4827-B754-D070F1716868

Q37395388-5E260D34-5EF4-42E1-A8E1-D445F0F3E43B

Q37395388-70FEFF1A-A435-431E-92F4-BA681EB1CBD1

P2860

Q37395388-1B3C14F2-50A8-4981-BAA1-6A24F5D4258E

Q37395388-219083E2-2AA0-4F39-8E4D-47F49F5C5712

Q37395388-2C95D09D-2A40-4BDB-9641-D622C9B9DA2E

Q37395388-3C7F65A6-095E-43C9-B604-0A4B3C894F25

Q37395388-405F0961-A03C-427D-AEC1-AD3C71B97B5D

Q37395388-4376BB9C-C5E4-424D-9520-9BBFC85953D4

Q37395388-4D643B34-BCE1-4D4C-95C6-A37B6EF29808

Q37395388-4FB67D07-5DE0-4189-BC2F-9598D6386210

Q37395388-6050C86D-CFF4-41F5-90BC-E7726A6B1F6A

Q37395388-68381956-6963-4443-A75B-B0E5119E0801

P304

Q37395388-076F9D70-521D-45E1-AD1C-BDA046EDC244

P31

Q37395388-A471A09A-D528-4715-AEBE-B5920865B9FA

P356

Q37395388-EE540A81-E286-4848-B4EA-87527690E418

P433

Q37395388-7548E34B-39D3-4175-BF8D-55E86DED39C6

P478

Q37395388-7D9400BB-457B-4122-A08D-8B6DFB14A70F

P577

Q37395388-6EFB3611-21DB-4D78-B77F-A51EAF5BFD36

P5875

Q37395388-626BE1B3-7BE1-4895-94A8-A76426DFFE06

P698

Q37395388-088AB50F-8C81-421F-A85A-980AADF7FA4F

P921

Q37395388-024FB3B8-227D-45E8-9DFB-57303CFD923A

P932

Q37395388-F84D3D22-E5CD-4C3E-9824-1726018E9D91

P356

P1433

The Journal of Pathology

P1476

Distinct evolutionary trajecto ...... spatial mutational profiling.

@en

P2093

Ali Bashashati

http://www.w3.org/2001/XMLSchema#string

Alicia Tone

http://www.w3.org/2001/XMLSchema#string

Andrew Roth

http://www.w3.org/2001/XMLSchema#string

Blake Gilks

http://www.w3.org/2001/XMLSchema#string

David G Huntsman

http://www.w3.org/2001/XMLSchema#string

Gavin Ha

http://www.w3.org/2001/XMLSchema#string

Jamie Rosner

http://www.w3.org/2001/XMLSchema#string

Janine Senz

http://www.w3.org/2001/XMLSchema#string

Jessica N McAlpine

http://www.w3.org/2001/XMLSchema#string

Jiarui Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Mutational processes molding the genomes of 21 breast cancers

A census of human cancer genes

LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.

Integrated genomic analyses of ovarian carcinoma

A genetic model for colorectal tumorigenesis

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

The clonal evolution of tumor cell populations

Genome remodelling in a basal-like breast cancer metastasis and xenograft

The cancer genome

P304

21-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4230

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

231

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

239948007

http://www.w3.org/2001/XMLSchema#string

P698

23780408

http://www.w3.org/2001/XMLSchema#string

P921

P932

3864404

http://www.w3.org/2001/XMLSchema#string